Item 9 Labs Corp (INLB)
0.0001
0.00 (0.00%)
USD |
OTCM |
May 17, 15:34
Item 9 Labs Free Cash Flow: -2.597M for June 30, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2023 | -2.597M |
| March 31, 2023 | -4.758M |
| December 31, 2022 | -6.294M |
| September 30, 2022 | -7.713M |
| June 30, 2022 | -5.154M |
| March 31, 2022 | -7.002M |
| December 31, 2021 | -8.560M |
| September 30, 2021 | -8.232M |
| June 30, 2021 | -9.211M |
| March 31, 2021 | -5.870M |
| December 31, 2020 | -3.47M |
| September 30, 2020 | -1.548M |
| June 30, 2020 | -3.968M |
| March 31, 2020 | -6.963M |
| December 31, 2019 | -8.531M |
| September 30, 2019 | -8.851M |
| June 30, 2019 | -7.263M |
| March 31, 2019 | -4.176M |
| December 31, 2018 | -2.308M |
| September 30, 2018 | -1.518M |
| June 30, 2018 | -0.5447M |
| March 31, 2018 | -0.069M |
| December 31, 2017 | 0.0187M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.0689M |
| June 30, 2017 | -0.0838M |
| March 31, 2017 | -0.0942M |
| December 31, 2016 | -0.2719M |
| September 30, 2016 | -0.3397M |
| June 30, 2016 | -0.4568M |
| March 31, 2016 | -0.6325M |
| December 31, 2015 | -0.6021M |
| September 30, 2015 | -0.7476M |
| June 30, 2015 | -0.7343M |
| March 31, 2015 | -0.7768M |
| December 31, 2014 | -0.732M |
| September 30, 2014 | -0.7386M |
| June 30, 2014 | -0.5855M |
| March 31, 2014 | -0.5278M |
| December 31, 2013 | -0.7264M |
| September 30, 2013 | -0.3891M |
| June 30, 2013 | -0.5749M |
| March 31, 2013 | -0.515M |
| December 31, 2012 | -0.204M |
| June 30, 2012 | 0.1556M |
| March 31, 2012 | -0.0784M |
| December 31, 2011 | -0.0404M |
Free Cash Flow Range, Past 5 Years
-9.211M
Minimum
Jun 2021
-1.548M
Maximum
Sep 2020
-6.234M
Average
-6.963M
Median
Mar 2020
Free Cash Flow Benchmarks
| Humanigen Inc | -64.32M |
| Cannabis Global Inc | -- |
| Cantabio Pharmaceuticals Inc | -- |
| Affymax Inc | -- |
| Statera BioPharma Inc | -- |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 0.1501M |
| Cash from Investing (Quarterly) | -0.0628M |
| Cash from Financing (Quarterly) | -0.005M |
| Free Cash Flow Per Share (Quarterly) | 0.0009 |
| Free Cash Flow to Equity (Quarterly) | -0.8776M |
| Free Cash Flow to Firm (Quarterly) | 3.037M |